Literature DB >> 19763694

Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.

Kaitlyn J Kelly1, Joyce Wong, Rebecca Gladdy, Kimberly Moore-Dalal, Yanghee Woo, Mithat Gonen, Murray Brennan, Peter Allen, Yuman Fong, Daniel Coit.   

Abstract

BACKGROUND: Positive peritoneal fluid cytology predicts poor outcome in patients with resected pancreatic cancer. Reverse transcription-polymerase chain reaction (RT-PCR) has been proposed as a more sensitive means of detection of peritoneal micrometastases than conventional cytology. The clinical significance of RT-PCR positivity in the absence of other evidence of peritoneal disease is unknown. The purpose of the current study was to determine the outcome RT-PCR positive/cytology-negative patients who underwent potentially curative resection.
METHODS: Peritoneal washings were collected prospectively from 115 patients with pancreatic cancer undergoing diagnostic laparoscopy at a single institution. Specimens were analyzed by a cytopathologist and by RT-PCR for carcinoembryonic antigen (CEA).
RESULTS: Of the 115 patients, 62 (54%) underwent R0 resection. Eleven of the 62 patients (18%) had peritoneal washings that were negative by conventional cytology but positive for CEA by RT-PCR. Those 11 patients experienced early peritoneal and overall disease recurrence versus those who were RT-PCR negative (P = 0.001, P = 0.003, respectively) independent of nodal status.
CONCLUSIONS: RT-PCR for CEA is a sensitive and specific method for the detection of clinically significant peritoneal micrometastases from pancreatic cancer and it might identify a subgroup of patients with otherwise negative findings at staging laparoscopy who might respond better to treatment other than primary surgical resection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763694      PMCID: PMC3275341          DOI: 10.1245/s10434-009-0683-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

Review 1.  Laparoscopy and peritoneal cytology in the staging of pancreatic cancer.

Authors:  R E Jimenez; A L Warshaw; C Fernandez-Del Castillo
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

2.  Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings.

Authors:  Kazuhiko Mori; Kazuhiko Aoyagi; Tetsuya Ueda; Inaho Danjoh; Yasuhiro Tsubosa; Kazuyoshi Yanagihara; Yoshihiro Matsuno; Mitsuru Sasako; Hiromi Sakamoto; Ken ichi Mafune; Michio Kaminishi; Teruhiko Yoshida; Masaaki Terada; Hiroki Sasaki
Journal:  Biochem Biophys Res Commun       Date:  2004-01-23       Impact factor: 3.575

3.  Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma.

Authors:  T J Howard; A C Chin; E W Streib; K K Kopecky; E A Wiebke
Journal:  Am J Surg       Date:  1997-09       Impact factor: 2.565

Review 4.  Outcomes in oncologic surgery: does volume make a difference?

Authors:  David J Bentrem; Murray F Brennan
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

5.  Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma.

Authors:  N B Merchant; K C Conlon; P Saigo; E Dougherty; M F Brennan
Journal:  J Am Coll Surg       Date:  1999-04       Impact factor: 6.113

6.  Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer.

Authors:  S Yachida; N Fukushima; M Sakamoto; Y Matsuno; T Kosuge; S Hirohashi
Journal:  Br J Surg       Date:  2002-05       Impact factor: 6.939

7.  Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography.

Authors:  Antonio Soriano; Antoni Castells; Carmen Ayuso; Juan Ramón Ayuso; Maria Teresa de Caralt; Maria Angels Ginès; Maria Isabel Real; Rosa Gilabert; Llorenç Quintó; Antoni Trilla; Faust Feu; Xavier Montanyà; Laureano Fernández-Cruz; Salvador Navarro
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

8.  Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy.

Authors:  Timothy K Williams; Ernest L Rosato; Eugene P Kennedy; Karen A Chojnacki; Jocelyn Andrel; Terry Hyslop; Cataldo Doria; Patricia K Sauter; Jordan Bloom; Charles J Yeo; Adam C Berger
Journal:  J Am Coll Surg       Date:  2008-12-18       Impact factor: 6.113

9.  Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer.

Authors:  M Nishiyama; I Takashima; T Tanaka; K Yoshida; T Toge; N Nagata; S Iwamori; Y Tamura
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

Review 10.  Fluorescence in situ hybridization, comparative genomic hybridization, and other molecular biology techniques in the analysis of effusions.

Authors:  Jorge Sérgio Reis-Filho; Fernando Carlos de Landér Schmitt
Journal:  Diagn Cytopathol       Date:  2005-11       Impact factor: 1.582

View more
  13 in total

1.  Rt-PCR increases detection of submicroscopic peritoneal metastases in gastric cancer and has prognostic significance.

Authors:  Joyce Wong; Kaitlyn Jane Kelly; Arjun Mittra; Mithat Gonen; Peter Allen; Yuman Fong; Daniel Coit
Journal:  J Gastrointest Surg       Date:  2012-02-24       Impact factor: 3.452

2.  Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer.

Authors:  Hop S Tran Cao; Sharmeela Kaushal; Cristina A Metildi; Rhiana S Menen; Claudia Lee; Cynthia S Snyder; Karen Messer; Minya Pu; George A Luiken; Mark A Talamini; Robert M Hoffman; Michael Bouvet
Journal:  Hepatogastroenterology       Date:  2012-09

3.  Expression and prognostic relevance of tumor carcinoembryonic antigen in stage IB non-small cell lung cancer.

Authors:  Jian Wang; Yun Ma; Zhi-Hua Zhu; Dong-Rong Situ; Yi Hu; Tie-Hua Rong
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

4.  miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA).

Authors:  Guo-Long Liu; Xia Liu; Xiao-Bin Lv; Xiao-Pai Wang; Xi-Sheng Fang; Yi Sang
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 5.  Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver.

Authors:  Peter Thomas; R Armour Forse; Olga Bajenova
Journal:  Clin Exp Metastasis       Date:  2011-09-07       Impact factor: 5.150

6.  Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites.

Authors:  Naminatsu Takahara; Hiroyuki Isayama; Yousuke Nakai; Hironori Ishigami; Sohei Satoi; Suguru Mizuno; Hirofumi Kogure; Saburo Matsubara; Natsuyo Yamamoto; Hironori Yamaguchi; Minoru Tada; Joji Kitayama; Toshiaki Watanabe; Kazuhiko Koike
Journal:  Invest New Drugs       Date:  2016-06-23       Impact factor: 3.850

Review 7.  Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Victoria B Allen; Kurinchi Selvan Gurusamy; Yemisi Takwoingi; Amun Kalia; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2016-07-06

8.  Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer.

Authors:  Yanghee Woo; Zhifang Zhang; Annie Yang; Shyambabu Chaurasiya; Anthony K Park; Jianming Lu; Sang-In Kim; Susanne G Warner; Daniel Von Hoff; Yuman Fong
Journal:  J Am Coll Surg       Date:  2020-02-04       Impact factor: 6.113

Review 9.  Biomarkers as predictors of recurrence following curative resection for pancreatic ductal adenocarcinoma: a review.

Authors:  Sylvester N Osayi; Mark Bloomston; Carl M Schmidt; E Christopher Ellison; Peter Muscarella
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

10.  Cancer cells with p53 deletion detected by fluorescent in situ hybridization in peritoneal drainage fluid is correlated with early peritoneal seeding in resectable pancreatic cancer.

Authors:  Mee Joo Kang; Sung-Sik Han; Jin-Young Jang; Jae Woo Park; Wooil Kwon; Ye Rim Chang; Sun-Whe Kim
Journal:  J Korean Surg Soc       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.